Home
Conditions
Unspecified Adult Solid Tumor, Protocol Specific

Clinical trial condition

Unspecified Adult Solid Tumor, Protocol Specific

Explore clinical trials studying Unspecified Adult Solid Tumor, Protocol Specific. Study availability and eligibility vary by location and protocol.

616 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

Unspecified Adult Solid Tumor, Protocol Specific trial results

Completed

ILX23-7553 in Treating Patients With Solid Tumors That Have Not Responded to Previous Therapy

NCT00004926

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Locations: New Jersey Medical School Newark, New Jersey, United States

Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Polyglutamate Camptothecin in Treating Patients With Advanced Cancer

NCT00059917

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Combination Chemotherapy in Treating Patients With Metastatic Solid Tumors

NCT00003711

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Locations: Brooke Army Medical Center Fort Sam Houston, Texas, United States

San Antonio Cancer Institute San Antonio, Texas, United States

View Trial Details

Completed

Bortezomib in Treating Patients With Advanced Cancer and Kidney Dysfunction

NCT00054483

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Blood Protein Disorders, +74 more
Locations: University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States

View Trial Details

Completed

Irinotecan and 3-AP in Treating Patients With Metastatic or Unresectable Solid Tumors

NCT00084877

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Locations: University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States

View Trial Details

Completed

Combination Chemotherapy Plus Oblimersen in Treating Patients With Advanced Solid Tumors

NCT00054548

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Locations: University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States

View Trial Details

Completed

3-AP and Doxorubicin In Treating Patients With Metastatic or Refractory Solid Tumors

NCT00079014

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Locations: University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States

View Trial Details

Completed

Enzastaurin and Bevacizumab in Treating Patients With Locally Advanced or Metastatic Cancer

NCT00550927

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors

NCT00060255

Conditions: Amyloidosis, Blast Crisis, Blood Protein Disorders, +84 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Healthy Men

NCT00287833

Conditions: Unspecified Adult Solid Tumor, Protocol Specific
Locations: Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Unspecified Adult Solid Tumor, Protocol Specific

Unspecified Adult Solid Tumor, Protocol Specific trial results

Related conditions